Holderness Investments Company’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Holderness Investments Company's VRTX Position: Q2 2026 in Review
Holderness Investments Company increased its Vertex Pharmaceuticals (VRTX) stake by 6.1% in Q2 2026, buying an estimated $13.3K and bringing the position to 519 shares worth $258K. The position accounts for 0.04% of the portfolio, ranked #235.
Holderness Investments Company first reported a position in VRTX in Q2 2023 and has held it in 11 quarters since. The position peaked at $666K in Q2 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Holderness Investments Company held 519 shares of Vertex Pharmaceuticals worth $258K as of Q2 2026.
- Holderness Investments Company bought 30 Vertex Pharmaceuticals shares in Q2 2026, an estimated $13.3K.
- Vertex Pharmaceuticals made up 0.04% of Holderness Investments Company's portfolio in Q2 2026, its #235 holding.
- Holderness Investments Company first reported a position in Vertex Pharmaceuticals in Q2 2023 and has held it in 11 quarters since.
- Holderness Investments Company's Vertex Pharmaceuticals position peaked at $666K in Q2 2025.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Holderness Investments Company's 13F filing for Q2 2026, filed 12 Aug 2026.